Jenna Wesolowski

Jenna L. Wesolowski serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements determination through contract award and administration. She plays a critical role in ensuring compliance with federal procurement regulations while advancing mission-critical supply chain objectives. Her portfolio primarily involves complex procurements for pharmaceutical and biological manufacturing, requiring deep technical understanding of cGMP standards, cold chain logistics, and regulatory submissions. She routinely engages with contractors to negotiate terms, evaluate technical proposals, and ensure performance alignment with federal quality and safety benchmarks. While no specific contractor relationships are identified, her procurement patterns indicate consistent engagement with manufacturers holding specialized FDA-regulated production capabilities. She works with vendors capable of scaling high-purity active pharmaceutical ingredients and biologics under strict environmental controls, often requiring ISO-certified facilities and validated processes. Her contracting approach emphasizes vendor qualification, risk mitigation, and supply chain resilience, favoring partners with proven track records in regulated environments. Jenna’s contracting activity reflects a strong preference for unrestricted competitions, with 100% of her awards issued under non-set-aside authorities. This indicates a focus on maximizing competition among qualified industry players rather than socioeconomic set-asides, suggesting her acquisitions prioritize technical capability and operational readiness over socioeconomic categorization. Her approach aligns with mission-critical needs where specialized manufacturing expertise is the primary selection criterion. Her primary NAICS focus lies in pharmaceutical preparation manufacturing (325412), with secondary emphasis on biological product manufacturing (325414), reflecting expertise in drug formulation, sterile compounding, and biologic production. She also engages with industrial gas and natural gas distribution sectors to support laboratory and manufacturing infrastructure needs. Her domain expertise centers on regulated life sciences manufacturing, requiring intimate knowledge of FDA guidelines, GxP compliance, and supply chain integrity in high-stakes healthcare environments.